Zobrazeno 1 - 10
of 341
pro vyhledávání: '"Mehmet Asim, Bilen"'
Autor:
Sean T Evans, Yash Jani, Caroline S Jansen, Ahmet Yildirim, Ecem Kalemoglu, Mehmet Asim Bilen
Publikováno v:
Cancer Biology & Therapy, Vol 25, Iss 1 (2024)
ABSTRACTThe introduction of novel immunotherapies has significantly transformed the treatment landscape of genitourinary (GU) cancers, even becoming the standard of care in some settings. One such type of immunotherapy, immune checkpoint inhibitors (
Externí odkaz:
https://doaj.org/article/082b3f99543f4a1ea7b9fa6358747071
Autor:
Seema Mustafa, Caroline S Jansen, Yash Jani, Sean Evans, Tony Z Zhuang, Jacqueline Brown, Bassel Nazha, Viraj Master, Mehmet Asim Bilen
Publikováno v:
Biomarker Insights, Vol 19 (2024)
In the past decade, immune checkpoint inhibitors (ICI) have been approved for treatment of genitourinary malignancies and have revolutionized the treatment landscape of these tumors. However, despite the remarkable success of these therapies in some
Externí odkaz:
https://doaj.org/article/017274fc0bba4e15975ffecd899cb669
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
In this review, we aim to provide a comprehensive assessment of the evolving landscape of the perioperative management in renal cell carcinoma (RCC), emphasizing its dynamic and intricate nature. We explore academic and clinical insights into the per
Externí odkaz:
https://doaj.org/article/f69fa3ef76bc489793bc0fd865c1b941
Autor:
Caroline S. Jansen, Yujin Choi, Sean T. Evans, Rachel Greenwald, Joseph A. Behnke, Caitlin Hartman, Haydn Kissick, Lara R. Harik, Mehmet Asim Bilen
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Extrarenal clear cell renal cell carcinoma (eccRCC) is a rare type of RCC that arises in areas other than the kidney. Given its rarity, consensus guidelines for optimal treatment of eccRCC have not been established, and the literature is lacking any
Externí odkaz:
https://doaj.org/article/b957ea377e384a84a09b869d05f9bc07
Autor:
Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron, Greta Anne Russler, Lauren Yantorni, Sarah Caulfield, Jacqueline T. Brown, Jamie M. Goldman, Bassel Nazha, Bradley C. Carthon, Wayne B. Harris, Omer Kucuk, Viraj A Master, Mehmet Asim Bilen
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 52-57 (2022)
Introduction: There are three combination immune checkpoint inhibitor (ICI)–based regimens in the first-line setting for metastatic renal cell carcinoma (mRCC). Currently, there is limited real-world data for clinical outcomes and toxicity in mRCC
Externí odkaz:
https://doaj.org/article/3b523ccfbd2e4ae9ba07ac843f39a4e8
Autor:
Alexandra Medline, Eric Midenberg, Dattatraya Patil, Sean Evans, Nikhil Vettikattu, Fatima Kamal, Kenneth Ogan, Sarah P. Psutka, Mehmet Asim Bilen, Viraj A. Master
Publikováno v:
JCSM Rapid Communications, Vol 5, Iss 2, Pp 205-211 (2022)
Abstract Background Preoperative skeletal muscle deficiency is an established risk factor for poor survival outcomes in patients with renal cell carcinoma (RCC). However, given the dynamic nature of skeletal muscle associated with malignancy, there i
Externí odkaz:
https://doaj.org/article/5801308526a844d2b837cb3880bb9e49
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/6454908bfd214dbaa717e2bb9b3bf6cf
Autor:
Jacqueline T. Brown, Vikram M. Narayan, Shreyas S. Joshi, Lara Harik, Ashesh B. Jani, Mehmet Asim Bilen
Publikováno v:
Cancer Treatment and Research Communications, Vol 34, Iss , Pp 100663- (2023)
Urothelial carcinoma accounts for approximately 90% of all bladder cancer diagnoses. Localized, muscle-invasive disease is often managed with a multidisciplinary approach including either neoadjuvant chemotherapy (NAC) followed by radical cystectomy
Externí odkaz:
https://doaj.org/article/2d15cfb2dd024c29b7b884d6ad9c8807
Autor:
Tony Zibo Zhuang, Lara Harik, Seth Force, Agreen Hadadi, Mehmet Asim Bilen, Jacqueline T. Brown, Bradley C. Carthon, Jamie Goldman, Omer Kucuk, Viraj A. Master, Bassel Nazha
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma is a subject of debate. We report a durable complete response in a 62-year-old man Jehovah’s Witness with metastatic clear cell renal cell carcinoma who received
Externí odkaz:
https://doaj.org/article/82d35e8cfd2f4bd2a107b982a151d13f
Autor:
Benjamin N. Schmeusser, Dattatraya H. Patil, Eric Midenberg, Michelle I. Higgins, Joel Zaldumbide, Dylan J. Martini, Sean Steele, Milton Williams, Reza Nabavizadeh, Sarah P. Psutka, Kenneth Ogan, Mehmet Asim Bilen, Vraj A. Master
Publikováno v:
Data in Brief, Vol 45, Iss , Pp 108724- (2022)
Poor functional, nutritional, and muscle status is a significant negative predictor for surgical and survival outcomes in patients with cancer, including renal cell carcinoma. This dataset displays results from preoperative muscle composition analysi
Externí odkaz:
https://doaj.org/article/603c64fb15c14f918d78ca88a7710347